Company Facts
About Insitro
Insitro combines machine learning with high-throughput biology to accelerate drug discovery and development.
What is Insitro?
Insitro is a drug company that leverages machine learning and large-scale data to develop transformative new medicines. The company aims to accelerate drug discovery and bring better drugs to patients faster.
Who is Insitro for?
Insitro is primarily for patients in need of effective treatments, as well as healthcare providers and pharmaceutical partners looking for innovative drug development solutions.
When was Insitro founded?
Insitro was founded in 2018.
Who founded Insitro?
Insitro was founded by Daphne Koller, who is also the CEO.
What is Insitro best known for?
Insitro is best known for its innovative approach to drug discovery that combines machine learning with extensive biological data to create new therapeutic interventions.
Where AI Leaders Stay Informed
The latest AI intelligence, case studies, and research — delivered to your inbox every week.
Free to read. Unsubscribe anytime.
Is this your company?
Claim this profile to manage information and unlock premium features.